U.S. flag An official website of the United States government
  1. Home
  2. Science & Research
  3. FDA Technology Transfer Program
  4. Licensing and Collaboration Opportunities
  5. Method for Non-Invasive Identification of Individuals at Risk for Diabetes
  1. Licensing and Collaboration Opportunities

Method for Non-Invasive Identification of Individuals at Risk for Diabetes

The invention is a non-invasive technique for the detection of ocular pathologies, including molecular changes associated with diabetes. Raman spectra emitted from an eye that is subject to a laser probe provides information regarding early markers of diabetes or diabetes-induced ocular pathologies. The invention compares spectra taken from the subject under study to spectra from a normal subject. Multivariate statistical methods are used to obtain predictive information based on the detected spectra, and to diagnose or predict the onset or stage of progression of diabetes-induced ocular pathology.

Inventors:
Anthony Durkin
Marwood Ediger
Michelle Chenault

Intellectual Property:
U.S. Patent No. 6,721,583 issued 2004-04-13
PCT Application No. PCT/US99/27360

Licensing Contact:
Bill Ronnenberg, JD-MIP, MS
FDA Technology Transfer Program
10903 New Hampshire Ave.
Building WO1, Rm 4214
Silver Spring, MD 20993
Email: FDAInventionlicensing@fda.hhs.gov
Phone: 240-402-4561

OTT Reference No: E-091-1998/0
Updated: August 10, 2015